The Sodium glucose transporter 2 inhibitor with acute insulin treatment for controlling severe hyperglycemia in patients with type 2 Diabetes mellitus
- Conditions
- type2 diabetes mellitus
- Registration Number
- JPRN-UMIN000018997
- Lead Sponsor
- Toho University School of Medicine,Divsion of diabetes, metabolism and endocrinology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
(1) Type 1 diabetes mellitus patients or secondary diabetic mellitus (2) Patients who had myocardial infarction within 3 months, or obvious heart failure case (3) Patients who had the past of hypersensitivity for the used drug (4) Patients with diabetic ketoacidosis or diabetic coma or risk of diabetic coma (5) Patients with severe liver disease (6) Patients with severe renal disease (7) Patients with severe pancreas disease (8) Patients with hemoglobin (Hb) less than 11 g/dL (9) Patient during cancer treatment (10) Patients that the number of the platelets is less than 100,000 /mm3 (11) Patients with high diabetic neuropathy (12) Patients having a proliferative retinopathy (13) Patients with a serious infectious disease or a serious injury (14) Excessive common custom drinker (15) A pregnant woman or the woman who may be pregnant (16) In addition, the patient who judged inappropriate by an attendant physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.the dose of insulin and treatment period to manage hyperglycemia 2.measurement of energy expenditure and respiratory quotient by using the indirectcalorimetry
- Secondary Outcome Measures
Name Time Method